Treatment of thoracic actinomycosis: A retrospective analysis of 40 patients

Annals of Thoracic Medicine

Volumn 5, Issue 2, 2010, Pages 80-85

  Song, Jae Uk ^a   Park, Hye Yun ^a   Jeon, Kyeongman ^a   Um, Sang Won ^a   Kwon, O Jung ^a   Koh, Won Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Actinomycosis; drug therapy; thoracic diseases; treatment outcomes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT;

ACTINOMYCOSIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHOSCOPY; BRONCHUS STONE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE DURATION; EMPYEMA; ESOPHAGOBRONCHIAL FISTULA; FEMALE; FEVER; HEMOPTYSIS; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG DISEASE; LUNG LOBECTOMY; LUNG MYCOSIS; LUNG RESECTION; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PLEURA EFFUSION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SPUTUM; SURGICAL MORTALITY; THORACIC ACTINOMYCOSIS; THORAX DRAINAGE; THORAX PAIN; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77956023970     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.62470     Document Type: Article

References (18)

1. Bates M, Cruickshank G. Thoracic actinomycosis. Thorax 1957;12:99-124.
2. Kay EB. Actinomyces in chronic bronchopulmonary infections. Am Rev Tuberc 1948;57:322-329
3. Lu MS, Liu HP, Yeh CH, Wu YC, Liu YH, Hsieh MJ, et al. The role of surgery in hemoptysis caused by thoracic actinomycosis; a forgotten disease. Eur J Cardiothorac Surg 2003;24:694-698
4. Mabeza GF, Macfarlane J. Pulmonary actinomycosis. Eur Respir J 2003;21:545-551
5. Kinnear WJ, MacFarlane JT. A survey of thoracic actinomycosis. Respir Med 1990;84:57-59
6. Hsieh MJ, Liu HP, Chang JP, Chang CH. Thoracic actinomycosis. Chest 1993;104:366-370
7. Skoutelis A, Petrochilos J, Bassaris H. Successful treatment of thoracic actinomycosis with ceftriaxone. Clin Infect Dis 1994;19:161-162
8. Dalhoff K, Wallner S, Finck C, Gatermann S, Wiessmann KJ. Endobronchial actinomycosis. Eur Respir J 1994;7:1189-1191
9. Choi J, Koh WJ, Kim TS, Lee KS, Han J, Kim H, et al. Optimal duration of IV and oral antibiotics in the treatment of thoracic actinomycosis. Chest 2005;128:2211-2217
10. Kolditz M, Bickhardt J, Matthiessen W, Holotiuk O, Höffken G, Koschel D. Medical management of pulmonary actinomycosis: data from 49 consecutive cases. J Antimicrob Chemother 2009;63:839-841
11. Sudhakar SS, Ross JJ. Short-term treatment of actinomycosis: two cases and a review. Clin Infect Dis 2004;38:444-447
12. Kim TS, Han J, Koh WJ, Choi JC, Chung MJ, Lee JH, et al. Thoracic actinomycosis: CT features with histopathologic correlation. AJR Am J Roentgenol 2006;186:225-231
13. Smith AJ, Hall V, Thakker B, Gemmell CG. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother 2005;56:407-409
14. Weese WC, Smith IM. A study of 57 cases of actinomycosis over a 36-year period. A diagnostic 'failure' with good prognosis after treatment. Arch Intern Med 1975;135:1562-1568
15. Yildiz O, Doganay M. Actinomycoses and Nocardia pulmonary infections. Curr Opin Pulm Med 2006;12:228-234
16. Slade PR, Slesser BV, Southgate J. Thoracic actinomycosis. Thorax 1973;28:73-85.
17. Yew WW, Wong PC, Wong CF, Chau CH. Use of imipenem in the treatment of thoracic actinomycosis. Clin Infect Dis 1994;19:983-984
18. Wohlgemuth SD, Gaddy MC. Surgical implications of actinomycosis. South Med J 1986;79:1574-1578